EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comprehensive In Vitro, Genomic, Microbiota, and Subacute Toxicological Safety Characterization of Lactiplantibacillus plantarum ATA-LPC98052

Şükran Özdatlı Kurtuluş iD, Ertuğrul Osman Bursalıoğlu iD, Reyhan Aliusta, Betül Türker Şallı, Batuhan Cenk Özkan, Deniz Köşebent iD, Ahmet Arif Kurt, Abdurrahman Recep Bülbül, Fatih Hacımustafaoğlu iD, Bekir Çakıcı, Nazlı Gamze Bülbül iD, Emine Kızılay und 4 weitere

Nutrients · 2026

DOI: 10.3390/nu18172796 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2026. Verfasst von Şükran Özdatlı Kurtuluş und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Toxicology, Hamidiye Faculty of Pharmacy, University of Health Sciences, Istanbul 34668, Türkiye. Hauptthemen laut MEDLINE: Probiotics, Lactiplantibacillus plantarum, Gastrointestinal Microbiome. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lactiplantibacillus plantarum is a widely studied probiotic species; however, probiotic characteristics and safety profiles are strain-specific, requiring independent evaluation. This study characterized Lactiplantibacillus plantarum ATA-LPC98052 as a candidate probiotic raw material.

Methods

ATA-LPC98052 was evaluated for hemolysis, acid/bile tolerance, Caco-2 adhesion, cytotoxicity, and storage stability. Subacute oral safety was assessed in Wistar rats by gavage for 28 days at 1.2 × 1011 CFU/kg/day; the study design incorporated selected principles of OECD Test Guideline 407. Clinical, hematological, biochemical, organ-weight, and macroscopic endpoints were evaluated. Fecal microbiota was analyzed by 16S rRNA sequencing; WGS was used for taxonomic confirmation and genomic safety screening.

Results

ATA-LPC98052 was γ-hemolytic and maintained 60% viability at pH 1.5 and 96% at pH 5.0, while viability ranged from 74% to 82% across 0.1–0.5% bile salt concentrations. Caco-2 cell viability was 99%, adhesion exceeded 90%, and the lyophilized preparation remained stable for 15 months, maintaining 9.6 log10 CFU/g. Repeated oral administration caused no mortality or consistent treatment-related toxicological pattern. Longitudinal microbiota analysis showed no significant treatment × time effects on alpha diversity or Bray–Curtis community structure, and no genus-level MaAsLin2 association was FDR-significant. WGS confirmed L. plantarum identity and no contamination; ResFinder detected no acquired antimicrobial resistance determinants meeting specified thresholds, whereas CARD/RGI identified low-identity qacJ and vanY homologs requiring cautious interpretation.

Conclusion

ATA-LPC98052 demonstrated favorable in vitro probiotic characteristics, technological stability, gut microbiota-modulating potential, and a favorable subacute safety profile under the tested conditions; however, microbiota findings were exploratory, and phenotypic MIC testing remains warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsLactiplantibacillus plantarumGastrointestinal MicrobiomeAnimalsHumansCaco-2 CellsRats, WistarRatsMaleFecesHemolysisRNA, Ribosomal, 16SGenomicsFemale

Stichwörter der Autor:innen

Lactiplantibacillus plantarumgut microbiotasubacute oral toxicitywhole-genome sequencing

Substanzen

RNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Department of Pharmaceutical Toxicology, Hamidiye Faculty of Pharmacy, University of Health Sciences, Istanbul 34668, Türkiye.
  • Department of Medical Services and Techniques, Vocational School of Health Services, Sinop University, Sinop 57000, Türkiye.
  • Venar Sağlık A. S., Büyükesat Mah., Çayhane St., No: 35/A GOP, Çankaya, Ankara 06700, Türkiye.
  • ATABIO Technologies Co., Ltd., Teknopol Istanbul, Istanbul 34903, Türkiye.
  • SFA R&D Private Health Services Co., Ltd., Teknopark Istanbul, Istanbul 34890, Türkiye.
  • Department of Pharmaceutical Technology, Faculty of Pharmacy, Süleyman Demirel University, Isparta 32000, Türkiye.

ORCID-Profile: Şükran Özdatlı Kurtuluş, Ertuğrul Osman Bursalıoğlu, Deniz Köşebent, Fatih Hacımustafaoğlu, Nazlı Gamze Bülbül

Zitieren

APA

Kurtuluş, Ş. Ö., Bursalıoğlu, E. O., Aliusta, R., Türker Şallı, B., Özkan, B. C., Köşebent, D., Kurt, A. A., Bülbül, A. R., Hacımustafaoğlu, F., Çakıcı, B., Bülbül, N. G., Kızılay, E., Coşkun, R., Yıldırım, G., Sardas, S., & Aslan, İ. (2026). Comprehensive In Vitro, Genomic, Microbiota, and Subacute Toxicological Safety Characterization of Lactiplantibacillus plantarum ATA-LPC98052. Nutrients. https://doi.org/10.3390/nu18172796

Vancouver

Kurtuluş ŞÖ, Bursalıoğlu EO, Aliusta R, Türker Şallı B, Özkan BC, Köşebent D, et al. Comprehensive In Vitro, Genomic, Microbiota, and Subacute Toxicological Safety Characterization of Lactiplantibacillus plantarum ATA-LPC98052. Nutrients. 2026. doi:10.3390/nu18172796

BibTeX
@article{Kurtulu2026,
  author = {Kurtuluş, Şükran Özdatlı and Bursalıoğlu, Ertuğrul Osman and Aliusta, Reyhan and Türker Şallı, Betül and Özkan, Batuhan Cenk and Köşebent, Deniz and Kurt, Ahmet Arif and Bülbül, Abdurrahman Recep and Hacımustafaoğlu, Fatih and Çakıcı, Bekir and Bülbül, Nazlı Gamze and Kızılay, Emine and Coşkun, Ronayı and Yıldırım, Gamze and Sardas, Semra and Aslan, İsmail},
  title = {Comprehensive In Vitro, Genomic, Microbiota, and Subacute Toxicological Safety Characterization of Lactiplantibacillus plantarum ATA-LPC98052},
  journal = {Nutrients},
  year = {2026},
  doi = {10.3390/nu18172796}
}
Kostenlos starten →